These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 9288165)

  • 41. The glutamate receptor GluR5 agonist (S)-2-amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid and the 8-methyl analogue: synthesis, molecular pharmacology, and biostructural characterization.
    Clausen RP; Naur P; Kristensen AS; Greenwood JR; Strange M; Bräuner-Osborne H; Jensen AA; Nielsen AS; Geneser U; Ringgaard LM; Nielsen B; Pickering DS; Brehm L; Gajhede M; Krogsgaard-Larsen P; Kastrup JS
    J Med Chem; 2009 Aug; 52(15):4911-22. PubMed ID: 19588945
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A tetrazolyl-substituted subtype-selective AMPA receptor agonist.
    Vogensen SB; Frydenvang K; Greenwood JR; Postorino G; Nielsen B; Pickering DS; Ebert B; Bølcho U; Egebjerg J; Gajhede M; Kastrup JS; Johansen TN; Clausen RP; Krogsgaard-Larsen P
    J Med Chem; 2007 May; 50(10):2408-14. PubMed ID: 17455929
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel AMPA and kainate receptor antagonists containing the pyrazolo[1,5-c]quinazoline ring system: Synthesis and structure-activity relationships.
    Varano F; Catarzi D; Colotta V; Lenzi O; Filacchioni G; Galli A; Costagli C
    Bioorg Med Chem; 2008 Mar; 16(5):2617-26. PubMed ID: 18063372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 3D-QSAR studies for the binding affinity toward (R, S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor.
    Sharma RN; Thakar H; Vasu KK; Chaturvedi SC
    Acta Pharm; 2008 Sep; 58(3):335-45. PubMed ID: 19103570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ionotropic excitatory amino acid receptor ligands. Synthesis and pharmacology of a new amino acid AMPA antagonist.
    Madsen U; Sløk FA; Stensbøl TB; Bräuner-Osborne H; Lützhøft HH; Poulsen MV; Eriksen L; Krogsgaard-Larsen P
    Eur J Med Chem; 2000 Jan; 35(1):69-76. PubMed ID: 10733604
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
    Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO).
    Bjerrum EJ; Kristensen AS; Pickering DS; Greenwood JR; Nielsen B; Liljefors T; Schousboe A; Bräuner-Osborne H; Madsen U
    J Med Chem; 2003 May; 46(11):2246-9. PubMed ID: 12747796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AMPA (amino-3-hydroxy-5-methylisoxazole-4-propionic acid) receptors in human brain tissues.
    Sawutz DG; Krafte DS; Oleynek JJ; Ault B
    J Recept Signal Transduct Res; 1995 Jul; 15(6):829-46. PubMed ID: 7584514
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 5-(N-oxyaza)-7-substituted-1,4-dihydroquinoxaline-2,3-diones: novel, systemically active and broad spectrum antagonists for NMDA/glycine, AMPA, and kainate receptors.
    Cai SX; Huang JC; Espitia SA; Tran M; Ilyin VI; Hawkinson JE; Woodward RM; Weber E; Keana JF
    J Med Chem; 1997 Oct; 40(22):3679-86. PubMed ID: 9357535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differentiation of in vivo effects of AMPA and NMDA receptor ligands using drug discrimination methods and convulsant/anticonvulsant activity.
    Arnt J; Sánchez C; Lenz SM; Madsen U; Krogsgaard-Larsen P
    Eur J Pharmacol; 1995 Oct; 285(3):289-97. PubMed ID: 8575516
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tweaking Subtype Selectivity and Agonist Efficacy at (S)-2-Amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propionic acid (AMPA) Receptors in a Small Series of BnTetAMPA Analogues.
    Wang SY; Larsen Y; Navarrete CV; Jensen AA; Nielsen B; Al-Musaed A; Frydenvang K; Kastrup JS; Pickering DS; Clausen RP
    J Med Chem; 2016 Mar; 59(5):2244-54. PubMed ID: 26862980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo.
    Weiss B; Alt A; Ogden AM; Gates M; Dieckman DK; Clemens-Smith A; Ho KH; Jarvie K; Rizkalla G; Wright RA; Calligaro DO; Schoepp D; Mattiuz EL; Stratford RE; Johnson B; Salhoff C; Katofiasc M; Phebus LA; Schenck K; Cohen M; Filla SA; Ornstein PL; Johnson KW; Bleakman D
    J Pharmacol Exp Ther; 2006 Aug; 318(2):772-81. PubMed ID: 16690725
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The respective N-hydroxypyrazole analogues of the classical glutamate receptor ligands ibotenic acid and (RS)-2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid.
    Clausen RP; Hansen KB; Calí P; Nielsen B; Greenwood JR; Begtrup M; Egebjerg J; Bräuner-Osborne H
    Eur J Pharmacol; 2004 Sep; 499(1-2):35-44. PubMed ID: 15363949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective loss of [3H]kainic acid and [3H]AMPA binding in layer VI of frontal cortex in Huntington's disease.
    Wagster MV; Hedreen JC; Peyser CE; Folstein SE; Ross CA
    Exp Neurol; 1994 May; 127(1):70-5. PubMed ID: 7515353
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoradiographic characterization of the non-N-methyl-D-aspartate binding sites in human cerebellum using the antagonist [3H]6-cyano-7-nitroquinoxaline-2,3-dione.
    Hatziefthimiou A; Mitsacos A; Kouvelas ED
    J Neurosci Res; 1994 Feb; 37(3):392-7. PubMed ID: 7909852
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and pharmacological studies at the Gly/NMDA, AMPA and Kainate receptors of new oxazolo[4,5-c]quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring.
    Calabri FR; Colotta V; Catarzi D; Varano F; Lenzi O; Filacchioni G; Costagli C; Galli A
    Eur J Med Chem; 2005 Sep; 40(9):897-907. PubMed ID: 15919134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Magnesium prevents seizure-induced reduction in excitatory amino acid receptor (kainate and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) binding in pregnant rat brain.
    Hallak M; Hotra JW; Custodio D; Kruger ML
    Am J Obstet Gynecol; 2000 Oct; 183(4):793-8. PubMed ID: 11035315
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stereostructure-activity studies on agonists at the AMPA and kainate subtypes of ionotropic glutamate receptors.
    Johansen TN; Greenwood JR; Frydenvang K; Madsen U; Krogsgaard-Larsen P
    Chirality; 2003 Feb; 15(2):167-79. PubMed ID: 12520509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
    Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
    J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 4-hydroxy-1,2,5-oxadiazol-3-yl moiety as bioisoster of the carboxy function. Synthesis, ionization constants, and molecular pharmacological characterization at ionotropic glutamate receptors of compounds related to glutamate and its homologues.
    Lolli ML; Giordano C; Pickering DS; Rolando B; Hansen KB; Foti A; Contreras-Sanz A; Amir A; Fruttero R; Gasco A; Nielsen B; Johansen TN
    J Med Chem; 2010 May; 53(10):4110-8. PubMed ID: 20408529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.